Archive

Primary care network pharmacy – making it work

Written by Christine Clark | 28 Jan 2022

Steve Williams, Senior Clinical Pharmacist at Poole Bay and Bournemouth PCN describes how some critical factors need to be taken into account when planning and organising PCN pharmacy… read more.

INTRIGUE Phase III study of Qinlock fails to meet primary endpoint in gastrointestinal stromal tumor – Deciphera Pharmaceuticals

Written by Charlie King | 27 Jan 2022

Deciphera Pharmaceuticals announced top-line results from the INTRIGUE Phase III clinical study of Qinlock (ripretinib) in patients with gastrointestinal stromal tumor (GIST) previously treated with imatinib. The study… read more.

RCT of medicines optimisation in general practice

Written by Christine Clark | 27 Jan 2022

Steve Williams, Senior Clinical Pharmacist at Poole Bay and Bournemouth PCN explains the positive findings from a randomised controlled trial that evaluated the impact of a medicines’ optimisation… read more.

Fat injection appears to reduce pain in plantar fascitis

Written by Bruce Sylvester | 27 Jan 2022

Injection of a patient’s fat into the sole of the foot appears to offer relief from the pain of plantar fasciitis, researchers from a pilot study reported on… read more.

FDA grants Tentative Approval for Yutrepia to treat pulmonary arterial hypertension – Liquidia Corpn

Written by Charlie King | 26 Jan 2022

Liquidia Corporation has announced that the FDA granted tentative approval for Yutrepia (treprostinil) inhalation powder, previously referred to as LIQ 861. Yutrepia is indicated for the treatment of… read more.

Long-term pain after knee surgery reduced

Written by Charlie King | 26 Jan 2022

One hundred thousand knee replacement surgeries are carried out in the UK every year. Most of these operations take place to treat pain related to osteoarthritis. Unfortunately, each… read more.

What does a PCN pharmacist do?

Written by Christine Clark | 26 Jan 2022

The day-to-day work of a pharmacist in a Primary Care Network (PCN) embraces operational and strategic elements and this involves working closely with other members of the primary… read more.

Phase III FURI study of ibrexafungerp shows positive clinical results in multiple fungal infections – Scynexis

Written by Charlie King | 25 Jan 2022

Scynexis announced an oral presentation of analyses of interim data from its ongoing Phase III FURI study showing favorable clinical activity of oral Brexafemme (ibrexafungerp) in severe hospital-based… read more.

Even light drinking can be harmful to health

Written by Charlie King | 25 Jan 2022

Research reveals cardiovascular risk of consuming small quantities of alcohol. Drinking less than the UK’s recommended limit of 14 units of alcohol per week still increases the risk… read more.

Getting started as a PCN pharmacist

Written by Christine Clark | 25 Jan 2022

The NHS long term plan foresees the establishment of teams of clinical pharmacists in every primary care network (PCN). IMI spoke to Steve Williams, a senior clinical pharmacist… read more.

New comprehensive phase III data show first-in-class Tremfya provided durable improvements in measures of psoriatic arthritis through two years – Johnson & Johnson

Written by Charlie King | 24 Jan 2022

The Janssen Pharmaceutical Companies of Johnson & Johnson announced comprehensive efficacy and safety data from the DISCOVER–2 trial of Tremfya (guselkumab) were published in Arthritis & Rheumatology, representing… read more.

Vaping worsens frequency of COVID symptoms

Written by Bruce Sylvester | 24 Jan 2022

Electronic cigarette users who tested positive for COVID-19 reported a higher frequency of COVID-19 symptoms than similar patients who don’t vape, researchers reported on Jan.13, 2022 in the Journal… read more.

« Previous 1 … 63 64 65 66 67 … 70 Next »

Archive

Subscribe for our mailing list

Follow Us